Weight Loss Medication Canada: Options, Costs & Coverage

If you’ve been watching GLP-1 drugs reshape weight loss treatment in North America, Canada presents a particular puzzle: the same medications that cost a few hundred dollars monthly south of the border sit behind a patchwork of provincial restrictions, employer carve-outs, and out-of-pocket price tags that can stretch past $500 per month. Roughly 1.4 million Canadians are already using these drugs, but most are doing so without any public coverage for weight loss specifically. This guide breaks down which medications are available, what they actually cost, and where Canadians might find coverage—or where they’re likely to pay the full price themselves.

GLP-1 drugs monthly cost: $200-$400 · Wegovy market entry: May 2024 · Common meds: Ozempic, Wegovy, Mounjaro, Contrave · Xenical mechanism: Blocks fat absorption · Contrave type: Appetite suppressant

What is the most effective weight loss medication in Canada?

GLP-1 agonists dominate the effectiveness rankings for weight loss medications in Canada. Clinical evidence and guidance from Obesity Canada place semaglutide-based drugs at the top tier, with tirzepatide (Mounjaro) showing comparable or potentially stronger results in some trials.

GLP-1 agonists like semaglutide

Semaglutide works by mimicking the GLP-1 hormone that regulates appetite and insulin. Ozempic contains semaglutide but is approved for Type 2 diabetes—its weight loss effects occur off-label. Wegovy contains the same active ingredient at higher doses and holds Health Canada approval specifically for obesity treatment, having entered the Canadian market in May 2024. According to PolicyAdvisor, Wegovy costs $400–$570 CAD per month without insurance, compared to Ozempic at $200–$300 per month. The price gap reflects Wegovy’s higher-dose formulation and its dedicated weight-loss indication.

Other options like Contrave

Contrave combines bupropion and naltrexone in a single pill targeting brain chemistry rather than gut hormones. It works as an appetite suppressant but typically produces more modest weight loss results than GLP-1 injections. Xenical (orlistat) takes a mechanical approach, blocking fat-digesting enzymes in the intestines so that roughly 30% of dietary fat passes undigested. Neither approach matches the clinical outcomes of semaglutide or tirzepatide, though they cost significantly less and don’t require injection.

What weight loss drugs are covered in Canada?

The short answer: almost none for weight loss specifically. Public provincial drug plans across Canada—including Ontario Drug Benefit, BC PharmaCare, and Quebec’s public formulary—cover GLP-1 medications only for patients with diagnosed Type 2 diabetes. Wegovy’s weight-loss indication explicitly excludes it from most public coverage scenarios.

Provincial coverage variations

Coverage varies slightly by province, but the pattern holds: provincial programs treat obesity differently from diabetes. Ontario’s OHIP does not cover Wegovy for weight loss, and off-label use of Ozempic for weight management falls outside its coverage framework as well. According to Insurance Business Magazine, public plans limit semaglutide to diabetes patients, forcing obesity patients to pay out-of-pocket regardless of medical need. British Columbia’s PharmaCare follows the same diabetes-first logic, though its Provincial Academic Detailing service published an updated weight loss drug table in July 2025 as prescribers increasingly seek guidance on these medications.

OHIP specifics

Ontario residents with employer-sponsored insurance face a better but still incomplete picture. While some group plans cover Ozempic or Mounjaro when prescribed for diabetes, coverage for weight loss requires navigating prior authorization, documented BMI thresholds, and evidence of failed lifestyle modifications. Fewer than 20% of private drug plans in Canada cover obesity medications at all, according to Obesity Canada.

What is the alternative to Ozempic in Canada?

Canadians who cannot access Ozempic have several alternatives, though each carries trade-offs in cost, coverage eligibility, and effectiveness. The choice often comes down to whether the patient prioritizes maximum efficacy or manageable expenses.

Wegovy comparison

Wegovy stands as the most direct Ozempic alternative for weight loss specifically. Both contain semaglutide, but Wegovy’s dosing protocol is calibrated for obesity treatment rather than diabetes management. Wegovy costs $400–$570 per month compared to Ozempic’s $200–$300 range, a premium that reflects its dedicated indication rather than superior chemistry. The key difference: Wegovy may qualify for certain employer coverage scenarios where Ozempic’s off-label weight use does not.

Mounjaro and others

Mounjaro (tirzepatide) offers a different mechanism—dual GIP/GLP-1 receptor agonism—sometimes producing stronger weight loss than semaglutide. It costs $300–$450 per month at Canadian pharmacies and follows a similar access pattern: covered for diabetes indications, largely uncovered for weight loss. Contrave and Xenical remain as lower-cost options that don’t require injection, though their effectiveness trails GLP-1 drugs by a meaningful margin.

Can you buy weight loss drugs in Canada?

Yes—but not without a prescription, and not without significant out-of-pocket expense for most weight-loss indications. The Canadian Medical Association confirms that GLP-1 drugs require a prescription from a licensed healthcare provider, and their cost without coverage can reach several thousand dollars annually.

Prescription requirements

All GLP-1 medications in Canada require prescriptions. Physicians can prescribe Ozempic for its approved diabetes indication or off-label for weight loss. Wegovy requires a specific obesity diagnosis and typically documentation of BMI thresholds before prescribing. Nurse practitioners and certain specialists may also prescribe depending on provincial regulations. Online prescription services through platforms like Maple have expanded access, though insurers still apply their coverage criteria to these digital channels.

Online options

TeleTest and similar platforms allow Canadians to obtain GLP-1 prescriptions through online consultations, though the medication itself must be purchased at standard pharmacy rates. Compounded GLP-1 products are not permitted for use under most plans because Health Canada’s stabilized supply of approved products eliminates the compounding exemption. Patients should verify that any online service prescribing these medications requires proper clinical documentation—legitimate platforms won’t bypass the prescription requirement regardless of how the consultation is delivered.

How much do weight loss medications cost in Canada?

GLP-1 medications represent a significant ongoing expense for Canadians without coverage. Monthly costs range from roughly $200 to over $570 depending on the specific drug and dosage, translating to annual expenses that can exceed $7,000 per year.

Ozempic pricing

Ozempic costs between $200 and $300 CAD per month according to PolicyAdvisor, though historical pricing from August 2023 showed a specific rate of $205 CAD per month on the Maple platform. The medication requires weekly subcutaneous injection using prefilled pens. Without insurance or provincial coverage (available only for diabetes patients), patients absorb the full monthly cost indefinitely.

Mounjaro at Costco

Mounjaro pricing runs $300–$450 CAD monthly depending on dosage and pharmacy. Major retailers like Costco sometimes offer competitive pricing, though comparison shopping across pharmacies can yield meaningful savings. Patients should note that Costco pharmacy requires a membership for prescription services, which may affect total value calculations. Annual costs for tirzepatide-based treatment can approach $5,400 before any coverage.